Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,120

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

September 1, 2030

Study Completion Date

September 1, 2031

Conditions
Community-acquired Pneumonia
Interventions
DRUG

Doxycycline

Subjects will receive Doxycycline (orally or intravenously) in combination with beta-lactam therapy within 12 hours of hospital admission. Treatment duration will be 5-7 days.

DRUG

Azithromycin

Subjects will receive Azithromycin (orally or intravenously) in combination with beta-lactam therapy within 12 hours of hospital admission. Treatment duration will be 5-7 days.

Trial Locations (5)

32224

NOT_YET_RECRUITING

Mayo Clinic in Florida, Jacksonville

54601

NOT_YET_RECRUITING

Mayo Clinic Health System-La Crosse, La Crosse

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

56001

NOT_YET_RECRUITING

Mayo Clinic Health System-Mankato, Mankato

85259

NOT_YET_RECRUITING

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER